Screener
Madrigal Pharmaceuticals, Inc. MDGL EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050845
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, / As Revised 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, / As Revised 2025 |
|---|---|---|---|---|
| Denominator: | ||||
| Weighted average common shares outstanding | 23,072,084 | 22,207,017 | 23,015,961 | 22,149,492 |
| Pre-funded warrants | 3,605,790 | 3,605,790 | 3,605,790 | 3,605,790 |
| Weighted average earned PSUs | 97,600 | 50,000 | 97,600 | 34,254 |
| Series A preferred stock | 1,969,797 | 1,969,797 | 1,969,797 | 1,969,797 |
| Series B preferred stock | 400,000 | 400,000 | 400,000 | 400,000 |
| Basic and diluted weighted average number of shares outstanding | 29,145,271 | 28,232,604 | 29,089,148 | 28,159,333 |
| Basic and diluted net loss per common, Series A preferred, and Series B preferred share | $(1.99) | $(1.50) | $(5.24) | $(4.10) |
Item 1. Financial Statements (Unaudited):
FAQ
- What is Madrigal Pharmaceuticals, Inc.'s EPS (diluted)?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported EPS (diluted) of -$1.99 in Q2 2026.
- How has Madrigal Pharmaceuticals, Inc.'s EPS (diluted) changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s EPS (diluted) decreased by 4.7% year-over-year, from -$1.90 to -$1.99.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s EPS (diluted)?
- Over 4 years (2021 to 2025), Madrigal Pharmaceuticals, Inc.'s EPS (diluted) has grown at a -3.2% compound annual growth rate (CAGR), from -$14.61 to -$12.83.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Madrigal Pharmaceuticals, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude